Índice

• • ·Introduction

    Página :1

    John P Phair MD, Lowell S Young MD

    
• • ·Microbiology and Minimum Inhibitory Concentration Testing for Mycobacterium avium Complex Prophylaxis

    Página :2-10

    Clark B Inderlied, PhD

    Resumen Resumen Esquema Esquema  
• • ·Epidemiology of Mycobacterium avium Complex Disease

    Página :11-15

    C.Robert Horsburgh

    Resumen Resumen Esquema Esquema
• • ·Treatment of Mycobacterium avium in Human Immunodeficiency Virus-Infected Individuals

    Página :16-21

    Susan L Koletar

    Resumen Resumen Esquema Esquema  
• • ·Treatment of Pulmonary Mycobacterium avium Complex Lung Disease in Non-Acquired Immunodeficiency Syndrome (AIDS) Patients in the Era of the Newer Macrolides and Rifabutin

    Página :22-27

    David E Griffith MD, Richard J Wallace

    Resumen Resumen Esquema Esquema
• • ·Alternative Regimens for the Prophylaxis of Mycobacterium avium Complex in Acquired Immune Deficiency Syndrome (AIDS)

    Página :28-31

    Judith S Currier, MD, J.Allen McCutchan, MD

    Resumen Resumen Esquema Esquema
• • ·Critical Drug Interactions With Agents Used for Prophylaxis and Treatment of Mycobacterium avium Complex Infections

    Página :32-36

    Constance A Benson, MD

    Resumen Resumen Esquema Esquema
• • ·Rationale for the Use of Azithromycin as Mycobacterium avium Chemoprophylaxis

    Página :37-49

    Michael W Dunne, MD, George Foulds, PhD, James A Retsema, PhD

    Resumen Resumen Esquema Esquema  
• • ·Cost-Effectiveness of Prophylaxis for Mycobacterium avium Complex Disease

    Página :50-55

    Richard D Moore, MD, MHSC, Richard E Chaisson, MD

    Resumen Resumen Esquema Esquema